2012 European thyroid association guidelines for metastatic medullary thyroid cancer

Area of Science:

• Oncology
• Endocrinology

Background:

• Distant metastases are the primary cause of mortality in medullary thyroid cancer (MTC).
• Effective management strategies for MTC with distant metastases are crucial.

Purpose of the Study:

• To provide 21 recommendations for managing medullary thyroid cancer patients with distant metastases.
• To outline follow-up protocols, treatment selection criteria, and treatment modalities.

Main Methods:

• Recommendations based on recent clinical trial results.
• Guidance on local and systemic treatment options.
• Follow-up protocols considering biochemical markers (calcitonin, CEA) and imaging.

Main Results:

• Asymptomatic patients with low tumor burden and stable disease may benefit from local treatments and regular surveillance.
• Systemic treatment is indicated for symptomatic patients, those with high tumor burden, or disease progression.
• Novel targeted therapies, including kinase inhibitors (e.g., against RET, VEGFR), show promise.

Conclusions:

• Personalized treatment approaches are essential for medullary thyroid cancer patients with distant metastases.
• Regular monitoring and timely intervention based on disease status are key.
• Further research is needed to optimize outcomes with emerging targeted therapies.